# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Mary McLeod Bethune (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML043-SYN-TD
- Date: 1948-03-09
- Fictional facility: St. Posthumous Health Center
- Fictional author: Viola Harrington-Mbeki, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

New patient visit for four months of wheeze, night cough and breathlessness on exertion in a 72-year-old woman with long-standing asthma that was never confirmed: examination, chest X-ray, ECG, blood tests and BNP, and planning of lung function testing and an echocardiogram. **S**

## Historical basis

- Mary Jane McLeod was born on July 10, 1875, near Mayesville, South Carolina, the fifteenth of seventeen children of Samuel and Patsy McLeod. Her parents, and eight of her older siblings, had been enslaved; after emancipation the family bought five acres of land and farmed cotton. **D**
- She was the only McLeod child to get an education, first at a Presbyterian mission school near Mayesville and then at Scotia Seminary. In 1898 she married Albertus Bethune; they separated after about nine years without divorcing, and he died in 1918. **D**
- In 1904 she founded a school for Black girls in Daytona Beach, Florida. She opened McLeod Hospital there in 1911, which the National Park Service says played a critical role in containing the influenza pandemic of 1918, and she and her students faced down the Ku Klux Klan at the school. The school merged with the Cookman Institute (dated 1923 by the National Park Service; named Bethune-Cookman College in 1929 according to another reference), and she was its president until 1942. **D**
- She was president of the National Association of Colored Women from 1924, received the NAACP's Spingarn Medal in 1935, and founded the National Council of Negro Women on December 5, 1935. She directed the Division of Negro Affairs of the National Youth Administration from the mid-1930s until it closed in 1943 and led the informal group of Black federal advisers known as the Black Cabinet. She said of her place in Washington: "When they see me, they know that the Negro is present." **D**
- For many years she suffered from chronic asthma, which increasingly restricted her ability to travel, and after a particularly severe attack in 1942 she gave up the presidency of Bethune-Cookman College. **D**
- The guide to her foundation's papers lists "Bethune asthma attacks" as a major topic of her administrative correspondence in the first half of 1943, and describes her health problems as a recurrent subject of her correspondence in those years. **D**
- From 1935 she lived in a series of apartments in Washington, D.C., while keeping her home, known as the Retreat, on the campus in Daytona Beach. In December 1943 she and the National Council of Negro Women bought 1318 Vermont Avenue, which became the council's first national headquarters and her Washington residence. **D**

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- Her breathing wakes her at night and stops her climbing stairs, and she has had to travel less. **S**
- She has been told for years that it is asthma, or her weight, or her heart, and wants to know for certain which it is. **S**
- She wants to keep going to Washington for the council's meetings. **S**

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Medications and allergies

- Albuterol 90 mcg/actuation inhaler, two puffs as needed, from an urgent care visit four months ago (used alone, without an inhaled steroid) **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- 1942: Chronic asthma for many years, increasingly limiting her travel; a particularly severe attack in 1942, after which she gave up the presidency of the college **D** (CLM-0005)
- 1943: Repeated asthma attacks recorded in her correspondence **D** (CLM-0006)

## Procedures and immunizations

- 1948-03-09 to 1948-03-09: Chest X-ray, posteroanterior and lateral: mild hyperinflation; heart size normal (cardiothoracic ratio 0.48); no pulmonary edema, effusion, mass or consolidation **S**
- 1948-03-09 to 1948-03-09: Resting 12-lead ECG: sinus rhythm at 80 per minute; left ventricular hypertrophy by voltage criteria; no Q waves, ST changes or arrhythmia **S**
- 1946-05-14: Recombinant zoster vaccine, dose 2 of 2 **S**
- 1943-02-08: Tdap vaccine **S**

## Family history

- No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

## Measurements

Hemoglobin: 12.9 g/dL; White cell count: 7.6 10*3/uL; Blood eosinophils: 0.42 10*3/uL; Platelets: 268 10*3/uL; Sodium: 140 mmol/L; Potassium: 4.1 mmol/L; Creatinine: 0.92 mg/dL; eGFR (CKD-EPI 1943): 66 mL/min/1.73 m²; Glucose: 102 mg/dL (high); Hemoglobin A1c: 5.9% (high); TSH: 2.2 mIU/L; BNP: 48 pg/mL; Total cholesterol: 228 mg/dL (high); HDL cholesterol: 56 mg/dL; Triglycerides: 140 mg/dL; LDL cholesterol: 144 mg/dL (high); Urine albumin-to-creatinine ratio: 18 mg/g; PHQ-2: 1; Asthma Control Test: 13. All results are synthetic.

BP 152/88 mmHg; pulse 82 bpm; respirations 20/min; temperature 36.7 °C; oxygen saturation 95% on room air; weight 88 kg; BMI 33.1 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, dignified and forthright; frustrated that her breathing is slowing her work; PHQ-2 1; no thoughts of self-harm. Functional status: Independent in all activities of daily living; breathless on one flight of stairs and has cut back her travel because of night cough and breathlessness. Physical examination is intentionally limited. **S**

## Assessment

1. Wheeze, cough and breathlessness for four months: waking with cough and tight chest two or three nights a week, breathless on one flight of stairs, relieved by albuterol, worse with colds, dust and strong scents; known asthma for many years but never confirmed by lung function testing and never treated with an inhaled steroid. Asthma, COPD and heart failure to be distinguished: spirometry with bronchodilator response, FeNO and an echocardiogram booked; status draft. **S**
2. Blocked nose, thick postnasal drip and a reduced sense of smell for years, worse in the last year; no nosebleeds; never seen by an ear, nose and throat specialist; status draft. **S**
3. Gastro-esophageal reflux: heartburn and an acid taste two or three evenings a week, worse after late meals and lying down; no trouble swallowing, vomiting, black stools or weight loss; status draft. **S**
4. Obesity, class 1 (BMI 33.1); she wants to walk more and to keep up with her work, and agreed to talk about it; status draft. **S**

## Plan

- Pulmonology consultation in two weeks with spirometry before and after bronchodilator, DLCO and FeNO, to confirm or refute asthma, separate it from COPD and heart disease, and plan treatment. Guideline: CMID: Clinical Monitoring Intelligence Database, asthma and hypertension monographs (2026); Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020) **S**
- Work-up of wheeze and breathlessness: chest X-ray, ECG, blood count with eosinophils, BNP, TSH and kidney function today; transthoracic echocardiogram before the consultation; albuterol continued as needed until testing, holding it for six hours before spirometry. Guideline: Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020); Heidenreich PA, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary. J Am Coll Cardiol 2022;79(17):1757-1780 (PMID 35379504) (2022) **S**
- Home blood pressure readings twice daily for a week, with a validated upper-arm cuff, because clinic readings are raised. Guideline: CMID: Clinical Monitoring Intelligence Database, asthma and hypertension monographs (2026); 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025) **S**
- Equity safeguards: spirometry read with race-neutral GLI Global equations, plain explanation of every result, and a check at each visit that her symptoms are not put down to her weight or age. Guideline: Bhakta NR, et al. Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement. Am J Respir Crit Care Med 2023;207(8):978-995 (PMID 36973004) (2023); Pate CA, et al. Asthma Surveillance - United States, 2006-2018. MMWR Surveill Summ 2021;70(5):1-32 (PMID 34529643) (2021) **S**

## Guideline basis

- CMID: Clinical Monitoring Intelligence Database, asthma and hypertension monographs (2026), Aether Forge
- Global Strategy for Asthma Management and Prevention, 2025 update (2025), Global Initiative for Asthma
- 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020), National Heart, Lung, and Blood Institute (J Allergy Clin Immunol 2020;146(6):1217-1270)
- Heidenreich PA, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary. J Am Coll Cardiol 2022;79(17):1757-1780 (PMID 35379504) (2022), American Heart Association, American College of Cardiology and Heart Failure Society of America
- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology (J Am Coll Cardiol 2025)
- Bhakta NR, et al. Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement. Am J Respir Crit Care Med 2023;207(8):978-995 (PMID 36973004) (2023), American Thoracic Society
- Pate CA, et al. Asthma Surveillance - United States, 2006-2018. MMWR Surveill Summ 2021;70(5):1-32 (PMID 34529643) (2021), Centers for Disease Control and Prevention
